FewerJobs.
All jobs

Senior Director, DMPK

Cogent Biosciences Inc - Boulder, Colorado, United States

Posted Nov 17, 2026

Benefits

Parental leave
Not verified
Non-birth-parent leave
Not verified
Family-building benefits
  • Fertility benefits: Not verified
  • Adoption assistance: Not verified
  • Surrogacy assistance: Not verified
Mental health support
Not verified
Relocation assistance
Not verified
Childcare support
Not verified
Learning budget
Offered From the posting source checked Nov 18, 2026
Verification
Not verified checked Nov 20, 2026
Salary
$255K-$290K From the posting source checked Nov 18, 2026
401(k) match
Reported from DOL Form 5500 industry filing (not employer-specific)

Was this benefit information wrong? Tell us.

Role

Seniority
Director Plus From the posting source checked Nov 18, 2026

Schedule

Shift type
Not verified
Weekend work
Not verified

Company

Equity
Offered Verified - SEC 10-K source checked Nov 18, 2026

Application

Cover letter
Not verified
Assessment
Not verified
Deadline
Not stated

Where they hire

State eligibility is not yet verified.

About this role

Senior Director, DMPK Boulder, Colorado, United States Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing. The Role: The Senior Director, DMPK is responsible for providing scientific and strategic leadership for Drug Metabolism and Pharmacokinetics activities across Cogent's discovery and development portfolio. This individual will lead the DMPK function and develop and execute DMPK strategies that support small molecule programs from early discovery through candidate selection, IND-enabling studies, and clinical development. The successful candidate will bring deep expertise in ADME, pharmacokinetics, bioanalysis, and translational DMPK and will work closely with Medicinal Chemistry, Biology, Pharmacology, Toxicology, Clinical Pharmacology, and other cross-functional partners. This role will lead an internal DMPK team and oversee external CROs and partners to ensure high-quality data and timely execution of program objectives. The ideal candidate is a highly collaborative scientific leader

Read the full description at job-boards.greenhouse.io. FewerJobs shows a preview and links to the original posting.

Apply at job-boards.greenhouse.io

Apply link verified; last checked Nov 20, 2026.

What verified means

Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.

Related jobs